⌘K
Loading ticker…
As of 2026-08-25, TherapeuticsMD, Inc. (TXMD) has a 3-month relative strength percentile of 64 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 58. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.4%, relative volume 11.54×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
TXMD is in a stage 3 topping pattern, week 9. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 10.4% / 11.8%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
TXMD appears in 1 ETF as of Apr 2026: DFAC at 0.00% weight, $10K notional.
Held by 3 ETFs · $724K across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Apr 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| DFACDimensional U.S. Core Equity 2 ETF | 0.00% | $10K | new |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TXMD Jan avg: 13.20% median: 13.01% win: 75% σ: 18.68% n: 4 2022-04-12 → 2026-07-31 | TXMD Feb avg: -2.24% median: -0.63% win: 50% σ: 9.44% n: 4 2022-04-12 → 2026-07-31 | TXMD Mar avg: -10.03% median: -7.60% win: 0% σ: 10.43% n: 4 2022-04-12 → 2026-07-31 | TXMD Apr avg: -4.96% median: -5.60% win: 40% σ: 26.03% n: 5 2022-04-12 → 2026-07-31 | TXMD May avg: 11.29% median: 17.23% win: 80% σ: 9.06% n: 5 2022-04-12 → 2026-07-31 | TXMD Jun avg: -9.05% median: -0.72% win: 40% σ: 13.95% n: 5 2022-04-12 → 2026-07-31 | TXMD Jul avg: -8.35% median: -3.45% win: 20% σ: 17.36% n: 5 2022-04-12 → 2026-07-31 | TXMD Aug avg: 14.81% median: 3.41% win: 50% σ: 30.09% n: 4 2022-04-12 → 2026-07-31 (current) | TXMD Sep avg: -17.10% median: -16.13% win: 0% σ: 12.71% n: 4 2022-04-12 → 2026-07-31 | TXMD Oct avg: -7.52% median: -5.65% win: 25% σ: 16.56% n: 4 2022-04-12 → 2026-07-31 | TXMD Nov avg: 6.99% median: 6.37% win: 50% σ: 31.21% n: 4 2022-04-12 → 2026-07-31 | TXMD Dec avg: -8.57% median: -8.45% win: 25% σ: 25.35% n: 4 2022-04-12 → 2026-07-31 |